登录

IBA与Yale New Haven Health和Hartford HealthCare签署合同,在美国康涅狄格州安装Proteus®ONE质子治疗解决方案

IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US

GlobeNewswire | 2024-05-02 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


Louvain-La-Neuve, Belgium, 2 May 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International, for the installation of a Proteus®ONE1 compact proton therapy system.

2024年5月2日,比利时卢瓦因-拉涅夫-粒子加速器技术的世界领导者IBA(Ion Beam Applications S.A.,EURONEXT)今天宣布,它已与康涅狄格州质子治疗中心(the Connecticut Proton Therapy Center)签署了一份合同,该中心是耶鲁纽黑文健康(Yale New Haven Health)、哈特福德健康(Hartford HealthCare)和质子国际(Proton International)之间的合作项目,旨在安装Proteus®ONE1紧凑型质子治疗系统。

The contract includes a multi-year operation and maintenance agreement, and it is expected that the center will start treating patients in the spring of 2026. The first downpayment has been received. The Connecticut Proton Therapy Center will be the first of its kind in the state, and located in Wallingford, Connecticut.

该合同包括一份多年运营和维护协议,预计该中心将于2026年春季开始治疗患者。第一笔预付款已经收到。康涅狄格质子治疗中心将是该州首家此类中心,位于康涅狄格州沃林福德。

Proton therapy treatments will be provided by physicians affiliated with the Yale School of Medicine, the Yale New Haven Smilow Cancer Hospital, and Yale Cancer Center, which is a National Cancer Institute-designated (NCI) Comprehensive Cancer Center, and the Harford HealthCare Cancer Institute IBA’s Proteus®ONE, as the only user-centric compact Imaged Guided Intensity Modulated Proton Therapy solution, includes an isocentric Cone Beam Computed Tomography (CBCT) system and an open gantry enabling high-quality treatments with optimized patient throughput and excellent user and patient experience.

质子治疗将由隶属于耶鲁医学院、耶鲁纽黑文斯米洛癌症医院和耶鲁癌症中心的医生提供,耶鲁癌症中心是美国国家癌症研究所指定的(NCI)综合癌症中心,哈福德医疗保健癌症研究所IBA的Proteus®ONE是唯一以用户为中心的紧凑成像引导调强质子治疗解决方案,包括等中心锥形束计算机断层扫描(CBCT)系统和开放式机架,可实现高质量治疗,优化患者吞吐量,提供优异的用户和患者体验。

The typical end-user price for a Proteus®ONE system with a multi-year maintenance contract ranges between 40-50 million US dollars. Olivier Legrain, Chief Executive Officer of IBA, commented: “We are very proud to have signed this contract, which, once installed, will provide patients in Connecticut with access to cutting-edge proton therapy technology.

具有多年维护合同的Proteus®ONE系统的典型最终用户价格在4000-5000万美元之间。IBA首席执行官OlivierLegrain评论道:“我们非常骄傲地签署了这份合同,一旦安装,将为康涅狄格州的患者提供尖端质子治疗技术。

We look forward to working with Yale New Haven Health and Hartford HealthCare Corporation as they seek to deliver world-class .

我们期待着与耶鲁纽黑文健康和哈特福德医疗保健公司合作,寻求世界一流的服务。

Attachment

附件

240502-IBA-Yale-ProteusONE-EN-b

240502-IBA-ale-ProteusONE-EN-b

推荐阅读

Aging (Albany NY):小柴胡汤治疗乳腺癌的网络药理学机制探索及实验验证

MedSci 2024-05-17 13:00

药明生物:既没有人类基因组学业务亦未在其全球任何业务中收集人类基因组数据

格隆汇 2024-05-17 12:12

Kidney Int:组蛋白去乙酰化酶3(HDAC3)调控慢性肾脏病的炎症和纤维化作用

MedSci 2024-05-17 12:09

GlobeNewswire

8151篇

最近内容 查看更多

Erasca宣布RAS特许经营战略许可

2 小时后

结节病研究基金会发起临床试验公平联盟,以解决黑人患者面临的障碍

9 分钟前

Planet Green任命Steven Sirbovan先生为顾问委员会成员

38 分钟前

产业链接查看更多